Sunday, October 7, 2018
- 1:45pm-3:15pm
-
A Novel Telerehabilitation Strategy to Prevent Falls in Parkinson’s Disease (PD)
Technology · Hall 3FG
- 1:45pm-3:15pm
-
A panel of CSF and plasma biomarkers reveals novel biological insights into atypical parkinsonian syndromes
- 1:45pm-3:15pm
-
A randomized, double-blind, placebo-controlled Phase II Efficacy and Safety Study of the PDE10A inhibitor PF-02545920 in Huntington Disease (AMARYLLIS)
Huntington's Disease · Hall 3FG
- 1:45pm-3:15pm
-
A Registry of Real-World Outcomes Using Deep Brain Stimulation for the Treatment of Dystonia
Dystonia · Hall 3FG
- 1:45pm-3:15pm
-
A strategic approach to understand microsatellite repeat loci among Indian spinocerebellar ataxia patients
Ataxia · Hall 3FG
- 1:45pm-3:15pm
-
A Study on Combined Brain Positron Emission Tomography (PET) – Magnetic Resonance Imaging (MRI) Using Fluorodeoxyglucose (18FDG) (FDG-PET/MRI) in Premanifest Huntington’s Disease Gene-expansion Carriers
Huntington's Disease · Hall 3FG
- 1:45pm-3:15pm
-
A study on pre-adoption of a self-management application by Parkinson’s disease patients
Technology · Hall 3FG
- 1:45pm-3:15pm
-
A voxel-wise meta-analysis of gray matter abnormalities in essential tremor
Tremor · Hall 3FG
- 1:45pm-3:15pm
-
A Young Man with Multiple System Atrophy: A Case Report
- 1:45pm-3:15pm
-
A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson’s disease
Other · Hall 3FG
- «Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 60
- Next Page»